Sign In
Buy HTBX
$2.38
+0 (+0%)
At Close: Aug 17, 2022
10-Q: SPECTRUM PHARMACEUTICALS INC
10:11pm, Thursday, 07'th May 2020
(EDGAR Online via COMTEX) --
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Note Regarding Forward-Looking Statements...
Spectrum Pharmaceuticals Reports First Quarter 2020 Financial Results and Pipeline Update
12:00am, Thursday, 07'th May 2020
Spectrum Pharmaceuticals Reports First Quarter 2020 Financial Results and Pipeline Update
FDA approves Novartis drug for a hard-to-treat type of lung cancer
07:42pm, Wednesday, 06'th May 2020
Novartis AG on Wednesday received the U.S. Food and Drug Administration's approval for its drug to treat patients with a tough-to-treat form of lung cancer, the drugmaker said.
These 23 companies are working on coronavirus treatments or vaccines — here’s where things stand
06:50pm, Wednesday, 06'th May 2020
A mix of legacy drugmakers and small startups have stepped forward with plans to develop vaccines or treatments that target the infection caused by the novel...
Incyte Reports 2020 First Quarter Financial Results and Provides Updates on Key Clinical Programs
12:00am, Tuesday, 05'th May 2020
Incyte Reports 2020 First Quarter Financial Results and Provides Updates on Key Clinical Programs.
Genprex Issues April 2020 Shareholder Letter
12:00am, Monday, 04'th May 2020
Genprex issues a letter to shareholders, providing corporate and clinical updates.
2 Healthcare CEFs To Outperform: HQH And THW, Yields Up To 10%
12:20pm, Thursday, 30'th Apr 2020
Following the current crisis, healthcare stocks have been getting more attention. The reason is simple: More spending will go to healthcare, particularly biotec
Data From Merck at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care
12:01pm, Thursday, 30'th Apr 2020
- Not intended for US-, Canada- or UK-based media
Heat Biologics Reports Progress on COVID-19 Efforts and Timeline of Anticipated Q2 2020 Milestones
12:37pm, Wednesday, 29'th Apr 2020
DURHAM, NC / ACCESSWIRE / April 29, 2020 / Heat Biologics, Inc. ("Heat") (HTBX), a clinical-stage biopharmaceutical company specializing in the development of novel therapeutic and prophylactic vaccin
Head to Head Review: Amarillo Biosciences (OTCMKTS:AMAR) vs. Heat Biologics (OTCMKTS:HTBX)
06:02am, Wednesday, 29'th Apr 2020
Amarillo Biosciences (OTCMKTS:AMAR) and Heat Biologics (NASDAQ:HTBX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength
81 Biggest Movers From Friday
09:33am, Monday, 27'th Apr 2020
Gainers
Mesoblast Limited (NASDAQ: MESO) shares climbed 139.5% to close at $15.45 on Friday after the company reported 10 out of 12 patients with ventilator-dependent...
54 Stocks Moving In Friday's Mid-Day Session
04:22pm, Friday, 24'th Apr 2020
Gainers
Mesoblast Limited (NASDAQ: MESO) jumped 134.8% to $15.14 after the company reported 10 out of 12 patients with ventilator-dependent coronavirus infection survived...
